12:00 am Discussing the Current Anti-CGRP Status & the Challenges & Opportunities They Pose

  • Sheena Aurora Medical Fellow Global Launch Leader, Pain Eli Lilly
  • Daniel Mikol Executive Medical Director, Global Neuroscience Development Amgen

9:00 am Workshop B

  • Daniel Mikol Executive Medical Director, Global Neuroscience Development Amgen

Synopsis

Exploring How To Treat Each Patient, One Size Does Not Fit All

It is important in migraine drug development to look beyond the guidelines and learn from existing successful or unsuccessful trials. How to treat each patient and learn from the trials. Patient management and successful endpoints are critical to trial success.

This workshop will focus on:

  • Managing patients and knowing how to effectively treat at an early stage
  • Improving patient recruitment and retention
  • How to make a trial more attractive and adaptable to the patient
  • Exploration of alternative endpoints, such as functionality as a marker

9:00 am Opening remarks Day 1

9:30 am Lorem ipsum

10:00 am Dolor et simet

11:00 am Suspendisse nunc orci

12:00 pm Lunch and networking

1:30 pm Aenean interdum dolor enim

2:00 pm Ut lorem risus

3:00 pm Sed magna augue

4:00 pm Class aptent taciti sociosqu

  • Frank Walker Senior Enterprise Architect, Koch Industries Invited: DHL & Standard Chartered